Sökning: "Fatty acid transport protein"
Visar resultat 21 - 25 av 25 avhandlingar innehållade orden Fatty acid transport protein.
21. The role of GH in the regulation of energy homeostasis, lipid metabolism and cardiovascular function in transgenic mice
Sammanfattning : The aim of this thesis was, using two transgenic models, to investigate some metabolic diseases associated with acromegaly e.g. hypertension and alterations in lipid and lipoprotein metabolism. LÄS MER
22. Nutrient-regulated skeletal muscle metabolism and circadian clock
Sammanfattning : The prevalence of obesity has tripled in the last four decades, becoming a major risk for the development of cardiometabolic diseases such as type 2 diabetes. Obesity is associated with pathological storage of lipids in skeletal muscle, causing a major disturbance in metabolism. LÄS MER
23. Genetic and functional studies of MTTP and PLIN2 in relation to metabolic and cardiac dysfunction
Sammanfattning : Lipids including triglycerides, cholesterol, cholesterol esters and fatty acids are important sources for energy production, act as building blocks for intracellular compartments, are involved in numerous biological pathways and may act as signal molecules. Lipids are transported in blood as lipoproteins between organs, where they are immediately used in cellular processes or stored as cytosolic lipid droplets. LÄS MER
24. Transcriptional regulation of healthy and diabetic pancreatic beta-cell gene expression
Sammanfattning : Hyperglycemia, deficient insulin secretion, and insulin resistance are the characteristic pathogenetic features of type 2 diabetes (T2D), hallmarked by functional and survival defects of the insulin-producing islet beta-cell. The primary pathogenesis of T2D probably involves both genetic and environmental forces, and hyperglycemia and very commonly hyperlipidemia might further aggravate beta-cell dysfunction. LÄS MER
25. Fighting cardiometabolic disease : validation of new experimental models and therapeutic targets
Sammanfattning : The prevalence of cardiometabolic diseases (CMD) such as atherosclerotic cardiovascular diseases, type 2 diabetes mellitus and nonalcoholic fatty liver disease (NAFLD), has grown dramatically during the last decades. Hence, massive research efforts are allocated to identify the pathophysiological mechanisms and new therapeutic targets for these morbidities. LÄS MER